Asociación entre enfermedad de von Willebrand y angiodisplasia: ¿casualidad o causalidad?
Von Willebrand factor (vWf) is a fundamental multimeric plasma glycoprotein in the coagulation process. Its function is to mediate platelet adhesion and to stabilize circulating factor VIII. A functional or quantitative alteration of vWf gives rise to von Willebrand disease (vWD). The association be...
Guardado en:
Autores principales: | , , |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2020
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872020001001475 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872020001001475 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720200010014752021-02-02Asociación entre enfermedad de von Willebrand y angiodisplasia: ¿casualidad o causalidad?Salinas Laval,JoséTriantafilo,NicolásZúñiga,Pamela Angiodysplasia Gastrointestinal Hemorrhage von Willebrand Diseases Von Willebrand factor (vWf) is a fundamental multimeric plasma glycoprotein in the coagulation process. Its function is to mediate platelet adhesion and to stabilize circulating factor VIII. A functional or quantitative alteration of vWf gives rise to von Willebrand disease (vWD). The association between vWD and angiodysplasia was described in 1967, but it was only until 2011 that Starke et al demonstrated the in vitro and in vivo role of vWf in angiogenesis. Congenital or acquired vWf deficiency, especially of high molecular weight multimeters, not only favors bleeding, but also contributes to increased angiogenesis in these patients. The treatment should be focused both on the control of the acute episode of gastrointestinal bleeding, with vWf replacement therapy and local endoscopic treatment, as well as on the prevention of the progression of angiodysplasia and future bleeding. There are different published therapeutic approaches using vWf replacement that are not effective in all patients. Recently, angiogenesis inhibitor medications have been used.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.148 n.10 20202020-10-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872020001001475es10.4067/S0034-98872020001001475 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
topic |
Angiodysplasia Gastrointestinal Hemorrhage von Willebrand Diseases |
spellingShingle |
Angiodysplasia Gastrointestinal Hemorrhage von Willebrand Diseases Salinas Laval,José Triantafilo,Nicolás Zúñiga,Pamela Asociación entre enfermedad de von Willebrand y angiodisplasia: ¿casualidad o causalidad? |
description |
Von Willebrand factor (vWf) is a fundamental multimeric plasma glycoprotein in the coagulation process. Its function is to mediate platelet adhesion and to stabilize circulating factor VIII. A functional or quantitative alteration of vWf gives rise to von Willebrand disease (vWD). The association between vWD and angiodysplasia was described in 1967, but it was only until 2011 that Starke et al demonstrated the in vitro and in vivo role of vWf in angiogenesis. Congenital or acquired vWf deficiency, especially of high molecular weight multimeters, not only favors bleeding, but also contributes to increased angiogenesis in these patients. The treatment should be focused both on the control of the acute episode of gastrointestinal bleeding, with vWf replacement therapy and local endoscopic treatment, as well as on the prevention of the progression of angiodysplasia and future bleeding. There are different published therapeutic approaches using vWf replacement that are not effective in all patients. Recently, angiogenesis inhibitor medications have been used. |
author |
Salinas Laval,José Triantafilo,Nicolás Zúñiga,Pamela |
author_facet |
Salinas Laval,José Triantafilo,Nicolás Zúñiga,Pamela |
author_sort |
Salinas Laval,José |
title |
Asociación entre enfermedad de von Willebrand y angiodisplasia: ¿casualidad o causalidad? |
title_short |
Asociación entre enfermedad de von Willebrand y angiodisplasia: ¿casualidad o causalidad? |
title_full |
Asociación entre enfermedad de von Willebrand y angiodisplasia: ¿casualidad o causalidad? |
title_fullStr |
Asociación entre enfermedad de von Willebrand y angiodisplasia: ¿casualidad o causalidad? |
title_full_unstemmed |
Asociación entre enfermedad de von Willebrand y angiodisplasia: ¿casualidad o causalidad? |
title_sort |
asociación entre enfermedad de von willebrand y angiodisplasia: ¿casualidad o causalidad? |
publisher |
Sociedad Médica de Santiago |
publishDate |
2020 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872020001001475 |
work_keys_str_mv |
AT salinaslavaljose asociacionentreenfermedaddevonwillebrandyangiodisplasiacasualidadocausalidad AT triantafilonicolas asociacionentreenfermedaddevonwillebrandyangiodisplasiacasualidadocausalidad AT zunigapamela asociacionentreenfermedaddevonwillebrandyangiodisplasiacasualidadocausalidad |
_version_ |
1718437157838782464 |